The Phase I Clinical Study to Evaluate the Pharmacokinetics of Dw1029M in Healthy Male Volunteer

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

June 30, 2014

Conditions
Diabetic Kidney Disease
Interventions
DRUG

DW1029M300mg

DW1029M300mg PO Once

DRUG

DW1029M600mg

DW1029M300mg 2 tablets Once

DRUG

DW1029M1200mg

DW1029M300mg 4 tablets PO Once

Trial Locations (1)

561-712

Chonbuk National University Hospital, Jeonju-si, Jeollabuk-do

All Listed Sponsors
lead

Dong Wha Pharmaceutical Co. Ltd.

INDUSTRY